291 related articles for article (PubMed ID: 22662760)
21. In vitro effect of malachite green on Candida albicans involves multiple pathways and transcriptional regulators UPC2 and STP2.
Dhamgaye S; Devaux F; Manoharlal R; Vandeputte P; Shah AH; Singh A; Blugeon C; Sanglard D; Prasad R
Antimicrob Agents Chemother; 2012 Jan; 56(1):495-506. PubMed ID: 22006003
[TBL] [Abstract][Full Text] [Related]
22. Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans.
Navarro-Martínez MD; García-Cánovas F; Rodríguez-López JN
J Antimicrob Chemother; 2006 Jun; 57(6):1083-92. PubMed ID: 16585130
[TBL] [Abstract][Full Text] [Related]
23. In vitro studies on oxidative stress-independent, Ag nanoparticles-induced cell toxicity of
Radhakrishnan VS; Dwivedi SP; Siddiqui MH; Prasad T
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):91-96. PubMed ID: 29593404
[TBL] [Abstract][Full Text] [Related]
24. [Study on andrographolide-induced apoptosis of Candida albicans biofilm dispersion cells].
Wang C; Han N; Xu Z; Cheng H; Guan Y; Yun Y; Wang Y
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(3):362-5. PubMed ID: 22568241
[TBL] [Abstract][Full Text] [Related]
25. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
[TBL] [Abstract][Full Text] [Related]
26. Anti-Candida albicans effectiveness of citral and investigation of mode of action.
Lima IO; de Medeiros Nóbrega F; de Oliveira WA; de Oliveira Lima E; Albuquerque Menezes E; Cunha FA; Formiga Melo Diniz Mde F
Pharm Biol; 2012 Dec; 50(12):1536-41. PubMed ID: 23116193
[TBL] [Abstract][Full Text] [Related]
27. Species distribution and in vitro antifungal susceptibility of clinical Candida isolates from a university hospital in Turkey over a 5-year period.
Kiraz N; Oz Y
Med Mycol; 2011 Feb; 49(2):126-31. PubMed ID: 20718609
[TBL] [Abstract][Full Text] [Related]
28. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ
Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine an Antimalarial Drug, Exhibits Potent Antifungal Efficacy Against Candida albicans Through Multitargeting.
Basrani ST; Gavandi TC; Patil SB; Kadam NS; Yadav DV; Chougule SA; Karuppayil SM; Jadhav AK
J Microbiol; 2024 May; 62(5):381-391. PubMed ID: 38587590
[TBL] [Abstract][Full Text] [Related]
30. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
31. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
Khan MS; Malik A; Ahmad I
Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
[TBL] [Abstract][Full Text] [Related]
32. Amphotericin B resistance leads to enhanced proteinase and phospholipase activity and reduced germ tube formation in Candida albicans.
Kumar R; Shukla PK
Fungal Biol; 2010; 114(2-3):189-97. PubMed ID: 20943129
[TBL] [Abstract][Full Text] [Related]
33. Punicalagin triggers ergosterol biosynthesis disruption and cell cycle arrest in Cryptococcus gattii and Candida albicans : Action mechanisms of punicalagin against yeasts.
Silva TC; de Ávila RI; Zara ALSA; Santos AS; Ataídes F; Freitas VAQ; Costa CR; Valadares MC; Silva MDRR
Braz J Microbiol; 2020 Dec; 51(4):1719-1727. PubMed ID: 32856241
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of xanthones: evaluation of their effect on ergosterol biosynthesis by high-performance liquid chromatography.
Pinto E; Afonso C; Duarte S; Vale-Silva L; Costa E; Sousa E; Pinto M
Chem Biol Drug Des; 2011 Mar; 77(3):212-22. PubMed ID: 21244637
[TBL] [Abstract][Full Text] [Related]
35. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
36. Antifungal activity of novel synthetic peptides by accumulation of reactive oxygen species (ROS) and disruption of cell wall against Candida albicans.
Maurya IK; Pathak S; Sharma M; Sanwal H; Chaudhary P; Tupe S; Deshpande M; Chauhan VS; Prasad R
Peptides; 2011 Aug; 32(8):1732-40. PubMed ID: 21693143
[TBL] [Abstract][Full Text] [Related]
37. Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Sardari S; Mori Y; Kurosawa T; Daneshtalab M
Can J Microbiol; 2003 May; 49(5):344-9. PubMed ID: 12897828
[TBL] [Abstract][Full Text] [Related]
38. (+)-Medioresinol leads to intracellular ROS accumulation and mitochondria-mediated apoptotic cell death in Candida albicans.
Hwang JH; Hwang IS; Liu QH; Woo ER; Lee DG
Biochimie; 2012 Aug; 94(8):1784-93. PubMed ID: 22534194
[TBL] [Abstract][Full Text] [Related]
39. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
[TBL] [Abstract][Full Text] [Related]
40. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
